Antiarrhythmic Drug Administration before Electrical Cardioversion of Atrial Fibrillation: Is It Useful to Prevent Early Arrhythmia Recurrence?

  • G. Boriani
  • M. Biffi
  • G. Bronzetti
  • L. Frabetti
  • A. Capucci
  • A. Branzi
  • B. Magnani


Electrical cardioversion may restore sinus rhythm in approximately 90% of patients with chronic atrial fibrillation [1]. The most relevant clinical problem after successful cardioversion is represented by the risk of recurrence which may occur either in a very early phase (first minutes after electrical shock), in an early phase (first 24 hours), in the days following the procedure or several weeks or months later.


Atrial Fibrillation Sinus Rhythm Antiarrhythmic Drug Atrial Natriuretic Factor Atrial Fibrillation Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lown B, Amarasingham R, Neumann J (1962) New method for terminating cardiac arrhythmias. JAMA 182: 548–555PubMedCrossRefGoogle Scholar
  2. 2.
    Lundstrom T, Ryden L (1988) Chronic atrial fibrillation. Long term results of direct current cardioversion. Acta Med Scand 223: 53–59Google Scholar
  3. 3.
    Falk RH (1992) Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 117: 141–150PubMedCrossRefGoogle Scholar
  4. 4.
    Rossi M, Lown B (1967) The use of quinidine in cardioversion. Am J Cardiol 19: 234238Google Scholar
  5. 5.
    Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI (1991) Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation or flutter. Am J Cardiol 68: 41–46PubMedCrossRefGoogle Scholar
  6. 6.
    Szekely P, Wynne NA, Pearson DT, Batson GA, Sidens DA (1970) Direct current shock and antidysrhythmic drugs. Br Heart J 32: 209–218PubMedCrossRefGoogle Scholar
  7. 7.
    Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J (1990) Cardioversion electrica bajo la action de la quinidina. Rev Esp Cardiol 43: 604–609PubMedGoogle Scholar
  8. 8.
    Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J (1992) Electrical cardioversion after amiodarone administration. Am Heart J 123: 1536–1542PubMedCrossRefGoogle Scholar
  9. 9.
    Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M (1996) Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo controlled study. J Am Coll Cardiol 28: 700–706PubMedGoogle Scholar
  10. 10.
    Van Gelder IC, Crijns HJ, Van Gilst WH, De Lagen CD, Van Wijk LM, Lie KI (1989) Effects of flecainide on the atrial defibrillation threshold. Am J Cardiol 63: 112–116PubMedCrossRefGoogle Scholar
  11. 11.
    Szyska A, Baszynska-Wachoviak H, Cielinski A (1996) Impact of antiarrhythmic premedication on efficacy of electrical cardioversion. Eur Heart J 17 suppl: 490 (abstr)Google Scholar
  12. 12.
    Wijffels MCEF, Kirchof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92: 1954–1968PubMedCrossRefGoogle Scholar
  13. 13.
    Lipkin DP, Frenneaux M, Stewart R, Joshi J, Lowe T, McKenna WJ (1988) Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J 59: 572–577PubMedCrossRefGoogle Scholar
  14. 14.
    Manning WJ, Leeman DE, Gotch PJ, Come PC (1989) Pulsed doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13: 617–623PubMedCrossRefGoogle Scholar
  15. 15.
    Calkins H, El-Atassi R, Lean A, Kalbfleisch S, Borganelli M, Langberg J, Morady F (1992) Effect of the atrioventricular relationship on atrial refractoriness in humans. PACE 15: 771–778PubMedCrossRefGoogle Scholar
  16. 16.
    Ravelli F, Allessie MA (1995) Atrial stretch decreases refractoriness and induces atrial fibrillation in isolated rabbit heart. Circulation 92 (suppl I): I-754. (abstr)Google Scholar
  17. 17.
    Mookherjee S, Anderson G, Smulyan H, Vardan S (1991) Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure. Am J Cardiol 67: 377–380PubMedCrossRefGoogle Scholar
  18. 18.
    Clemo HF, Baumgarten CM, Stambler BS, Wood MA, Ellenbogen KA (1994) Atrial natriuretic factor: implications for cardiac pacing and electrophysiology. PACE 17: 7091Google Scholar
  19. 19.
    Crijns HJGM, Van Den Berg MP, Van Gelder IC, Van Veldhuisen DJ (1997) Management of atrial fibrillation in the setting of heart failure. Eur Heart J 18 (suppl K) (in press)Google Scholar
  20. 20.
    Singer I, Guarnieri T, Kupersmith J (1988) Implanted automatic defibrillators: effect of drugs and pacemakers. PACE 11: 2250–2262PubMedCrossRefGoogle Scholar
  21. 21.
    Sodemark T, Jonsson B, Olsson A, Oro L, Wallin H, Edhag O, Sjogren A, Danielsson M, Rosenhamer G (1975) Effect of quinidine on maintaining sinus rhythm after cardioversion of atrial fibrillation or flutter. A multicentre study from Stockholm. Br Heart J 37: 486–492Google Scholar
  22. 22.
    Boriani G, Biffi M, Capucci A, Bronzetti G, Sabbatani P, Frabetti L, Zannoli R, Branzi A, Magnani B (1996) Fibrillazione atriale: efficacia, sicurezza e tollerabilità della cardioversione elettrica endocavitaria a bassa energia. Cardiologia 41 (suppl 5 ): 47 (abstr)Google Scholar
  23. 23.
    Lok NS, Lau CP, Way TY, Wah HS (1995) Effect of sotalol on transvenous atrial defibrillation for acute and chronic atrial fibrillation. J Am Coll Cardiol 25: 109A (abstr)Google Scholar
  24. 24.
    Santini M, Pandozi C, Toscano S, Castro A, Altamura G, Jesi AP, Gentilucci G, Villani M (1996) Intracardiac cardioversion of chronic atrial fibrillation. Cardiostimolazione 14: 167 (abstr)Google Scholar
  25. 25.
    Boriani G, Biffi M, Capucci A, Sabbatani P, Bronzetti G, Frabetti L, Ayers GM, Magnani B (1997) Favourable effects of flecainide in transvenous low energy internal atrial cardioversion. PACE 20: 1440 (abstr)Google Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • G. Boriani
    • 1
  • M. Biffi
    • 1
  • G. Bronzetti
    • 1
  • L. Frabetti
    • 1
  • A. Capucci
    • 1
  • A. Branzi
    • 1
  • B. Magnani
    • 1
  1. 1.Istituto di CardiologiaUniversità di BolognaItaly

Personalised recommendations